ST. LOUIS, Sept. 25, 2012 /PRNewswire/ -- Monsanto Company today announced that it will provide a royalty-free research license to the academic community and other non-profit research institutions to a newly issued US Patent related to the Agrobacterium transformation method.
Today's announcement, which is expected to benefit the academic community and other crop researchers, has the potential to further advance research and development of new technologies in key dicot crop plants. Dicot crops include major row crops such as soybeans, cotton and canola, as well as specialty crops such as alfalfa, potatoes, tomatoes and sugarbeets.
"We hope that access to one of the leading agricultural biotechnologies can further both the enablement and development of key agriculture solutions for farmers and consumers alike," said Robb Fraley, Chief Technology Officer for Monsanto Company and also one of the leading scientists behind this breakthrough discovery.
The Agrobacterium transformation process was first invented by Monsanto scientists in the early 1980s. Today, plant researchers around the world use several transformation methods to introduce novel trait technologies into crop plants – some of the primary methods include the Agrobacterium transformation process and the biolistic transformation process. Through these methods and continued advancements in breeding, plant researchers have been able to develop crops with improved nutritional profiles, plants that can better mitigate the effects of drought, as well as other agronomic improvements such as herbicide-tolerance and insect-protection.
Fraley noted that the continued, successful development of crop products and novel agriculture technologies by both the public and private sector represents an important part of supporting the growing food, feed and fuel demands of our planet and its finite resources. Experts estimate that the agriculture sector will need to double food production to feed a growing global population estimated to be at 9 billion by mid-century.
Products developed through biotechnology have proven to be a valuable tool in protecting and advancing on-farm crop yields for farmers since their initial introduction in the mid-1990s and since that time have generated a number of secondary benefits beyond the farm.
In 2011, nearly 17 million farmers grew biotech crops on approximately 400 million acres in 29 countries around the world. From 1996 to 2010, ISAAA experts note that biotech crops have supported an increase in crop production estimated at US$78.4 billion and supported the alleviation of poverty by improving the productivity or income of millions of small-holder farmers. A recent summary report by the Food and Agriculture Organization of the United Nations and the European Commission Joint Research Centre highlighted that "models estimate that world food price increases would be significantly higher in the absence of [the] cultivation [of biotech crops], by 10 percent to 30 percent depending on the crop and the underlying assumptions." The JRC-FAO report noted that these "price effect benefits all consumers globally through trade."
"Royalty-free access to research tools like the Agrobacterium transformation process is critical for solving important global agricultural problems, establishing industry-academia collaborations, and training students," said David Conrad, Executive Director of NUtech Ventures, a nonprofit organization responsible for building partnerships between the University of Nebraska and the private sector. "We applaud Monsanto for this initiative and encourage other agribusiness companies to adopt a similar approach within the academic and non-profit sectors."
This week, the U.S. Patent and Trademark Office issued patent claims to Monsanto for this enabling technology following its original filing in 1983. With the patent's issuance, Monsanto wanted to underscore its support for the advancement of public sector research that can continue to deliver improved crops that are critically important for food security and our world's growing demands. Interested parties can access a downloadable request form for the royalty-free research license on the company's Facebook site at: www.facebook.com/MonsantoCo, on Monsanto's website at www.monsanto.com or by contacting the company at: firstname.lastname@example.org.
Monsanto remains committed to broadly licensing its seed, trait and enabling technologies to support research and commercial developments that benefit farmers and the customers they serve. Monsanto's Agrobacterium transformation technology has been previously licensed to other major technology developers for commercial purposes. The company noted it will continue to make commercial licenses available for this enabling technology as it has proven so beneficial to advancing innovation in global agriculture.
The company has a long-standing commitment of supporting partnerships and research collaborations with public agricultural researchers around the world. Monsanto's work is aimed at improving crops important for food security; providing advice on environmental stewardship and information on food safety; as well as providing access and licenses to patented technologies. Many of these partnerships are particularly important in developing countries, including cassava, corn, mustard, papaya potato, rice and sweet potato.
About Monsanto Company
Monsanto Company is a leading global provider of technology-based solutions and agricultural products that improve farm productivity and food quality. Monsanto remains focused on enabling both small-holder and large-scale farmers to produce more from their land while conserving more of our world's natural resources such as water and energy. To learn more about our business and our commitments, please visit: www.monsanto.com. Follow our business on Twitter® at www.twitter.com/MonsantoCo, on the company blog, Beyond the Rows at www.monsantoblog.com, or subscribe to our News Release RSS Feed.
Lee Quarles- 314-694-2330
Kelli Powers – 314-694-4003
SOURCE Monsanto Company